Anti-ENO1 antibody combined with metformin against tumor resistance: a novel antibody-based platform
Background Antibody-based platforms (i.e., ADC) have emerged as one of the most encouraging tools for the cancer resistance caused by cancer stem cells (CSCs) enrichment. Our study might provide a promising therapeutic direction against drug resistance and serve as a potential precursor platform for...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , , , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
PeerJ Inc.
2024-03-01
|
| মালা: | PeerJ |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://peerj.com/articles/16817.pdf |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|